DOC-003 / HPLC
Tirzepatide HPLC chromatogram
Analysed at 214 nm with manual integration. The peak-area result is method- and sample-specific, not a content result or future-batch specification.
Acylated peptide API
Tirzepatide API Raw Material for Qualified B2B Programs
Tirzepatide is a synthetic, acylated 39-residue peptide with agonist activity at the GIP and GLP-1 receptors. Its C20 fatty-diacid modification supports albumin binding. This API page separates reference identity from the supplied form, specification, batch evidence, and market-specific review.
Identity data confirms the named parent peptide. Formal documents govern the supplied form, counter-ion, grade, applicable specification, and batch identity.
- Formula
- C225H348N48O68
- CAS
- 2023788-19-2
- Average MW
- 4813.53 g/mol
Product introduction
Tirzepatide is a synthetic, acylated 39-residue peptide with agonist activity at the GIP and GLP-1 receptors. A C20 fatty-diacid modification supports albumin binding. For peptide API raw material sourcing, reference identity, proposed form, specification, related peptides, analytical evidence, target market, and batch records remain project-specific.
Reference identity
Product parameters
Public identity fields organize the first review. Formal specifications and batch records govern the proposed supplied material.
| Parameter | Reference / specification | Source and scope |
|---|---|---|
| Product name | Tirzepatide | Supplied form confirmed per project |
| CAS | 2023788-19-2 | Named reference identity; formal documents govern the supplied material |
| Formula | C225H348N48O68 | NIH PubChem reference identity Not a batch measurement; counter-ion and supplied form require confirmation |
| Average MW | 4813.53 g/mol | |
| Peptide class | 39 amino-acid residues | Reference sequence identity |
| Portfolio specification | ≥99% by HPLC | Batch-specific result and applicable method per CoA |
| Single impurity / storage | Confirm for the specification and batch | No universal limit or storage-temperature guarantee |
Sequence / structure 39-residue linear synthetic peptide with a hydrophilic linker and C20 fatty-diacid modification at Lys20.
Material definition
Identity data confirms the named parent peptide. Formal documents govern the supplied form, counter-ion, grade, applicable specification, and batch identity.
Packaging and supply handoff
Confirm the supplied form before planning the shipment.
Packaging, storage, documents, eligible U.S. warehouse pathway, destination, and timing are aligned only after the product and batch scope is clear.
- 01
Supplied form
Confirm counter-ion, grade, packaging configuration, and storage conditions.
- 02
Document handoff
Match specification, CoA, analytical support, and shipping records to the proposed batch.
- 03
Regional pathway
Review Los Angeles or New Jersey eligibility; stock, route, release, and timing remain order-specific.
Tirzepatide batch-supporting documents
Each entry preserves the sample, method, date, reported result, issuer information, and product mapping of its source record.
Batch record review
Original records connect the issuer, sample identity, batch, method, date, result, disclosure status, and product mapping in one traceable review.